Predictive Oncology Unveils $344 Million Aethir Treasury Model in Nasdaq-First Move

- Integration of Aethir's ATH token into a $344 million treasury strategy. - ATH trading activity soars and stock price climbs by 70%. Predictive Oncology, a Nasdaq-traded biotech firm using AI for cancer research, has officially adopted a $344.4 million digital asset treasury model utilizing Aethir's ATH token. This pioneering move makes Predictive Oncology the first Nasdaq-listed company to add a Decentralized Physical Infrastructure Network (DePIN) token to its balance sheet in such a substantial capacity. On September 29, 2025, the company announced the treasury initiative. Cointelegraph reported on the same day that it is structured through dual private placements that combine traditional equity financing with decentralized Web3 innovations. The initiative will bolster Predictive Oncology's advanced cancer research by leveraging Aethir's decentralized GPU infrastructure. This infrastructure supports cutting-edge AI functionalities through distributed computing resources, which aligns with the company's mission to innovate in personalized oncology treatments. The market responded swiftly to this groundbreaking development. As a result, Predictive Oncology’s stock price surged by more than 70%, moving the company beyond its previous penny-stock status, which had been characterized by limited revenue streams and recurring losses. In addition, trading volume for Aethir's ATH token skyrocketed, increasing by 330% over a 24-hour period. DNA Fund, a Web3-focused investment and advisory firm, crafted the capital strategy for this digital asset adoption, while BTIG acted as the placement agent. This move positions Predictive Oncology among an emerging cohort of small-cap public companies exploring digital assets to drive innovation and financial growth. According to data from CoinMarketCap on September 29, Aethir (ATH) traded at $0.058 as of 20:23 UTC, while its 24-hour trading volume surged by 94.43%.